Share
Off-Label Drugs: Initial Results of a National Survey: Pemd-91-12br (in English)
U. S. Government Accountability Office ( ; U. S. Government Accountability Office ( (Author)
·
Bibliogov
· Paperback
Off-Label Drugs: Initial Results of a National Survey: Pemd-91-12br (in English) - U. S. Government Accountability Office ( ; U. S. Government Accountability Office (
$ 13.26
$ 15.75
You save: $ 2.49
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My WishlistsIt will be shipped from our warehouse between
Wednesday, July 31 and
Thursday, August 01.
You will receive it anywhere in United States between 1 and 3 business days after shipment.
Synopsis "Off-Label Drugs: Initial Results of a National Survey: Pemd-91-12br (in English)"
Pursuant to a congressional request, GAO provided information about its survey of a nationally representative sample of oncologists to determine the extent to which health insurers denied patients reimbursement for off-label drug use, focusing on: (1) the prevalence of off-label drug use, and how its use varied by clinical, demographic, and geographic factors; (2) the extent to which third-party payers denied payment for such use; and (3) whether third-party payers' policies influenced the treatment of cancer patients. GAO presented a copy of the questionnaire it mailed to the random sample of oncologists, with the number or percentage of respondents answering each item. GAO noted that it received a 56-percent response rate to its mailing of 1,470 questionnaires.
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.
✓ Producto agregado correctamente al carro, Ir a Pagar.
